204 related articles for article (PubMed ID: 21801384)
1. Heteroarylketones inhibit astroglial interleukin-6 expression via a STAT3/NF-κB signaling pathway.
Schulz I; Engel C; Niestroj AJ; Zeitschel U; Menge K; Kehlen A; Meyer A; Rossner S; Demuth HU
J Neuroinflammation; 2011 Jul; 8():86. PubMed ID: 21801384
[TBL] [Abstract][Full Text] [Related]
2. Oncostatin M promotes excitotoxicity by inhibiting glutamate uptake in astrocytes: implications in HIV-associated neurotoxicity.
Moidunny S; Matos M; Wesseling E; Banerjee S; Volsky DJ; Cunha RA; Agostinho P; Boddeke HW; Roy S
J Neuroinflammation; 2016 Jun; 13(1):144. PubMed ID: 27287400
[TBL] [Abstract][Full Text] [Related]
3. Oncostatin M-induced blood-brain barrier impairment is due to prolonged activation of STAT3 signaling in vitro.
Takata F; Dohgu S; Matsumoto J; Machida T; Sakaguchi S; Kimura I; Yamauchi A; Kataoka Y
J Cell Biochem; 2018 Nov; 119(11):9055-9063. PubMed ID: 30076740
[TBL] [Abstract][Full Text] [Related]
4. Regulation of IL-17A responses in human airway smooth muscle cells by Oncostatin M.
Kwofie K; Scott M; Rodrigues R; Guerette J; Radford K; Nair P; Richards CD
Respir Res; 2015 Feb; 16(1):14. PubMed ID: 25849622
[TBL] [Abstract][Full Text] [Related]
5. Oncostatin M regulation of interleukin-6 expression in astrocytes: biphasic regulation involving the mitogen-activated protein kinases ERK1/2 and p38.
Van Wagoner NJ; Choi C; Repovic P; Benveniste EN
J Neurochem; 2000 Aug; 75(2):563-75. PubMed ID: 10899931
[TBL] [Abstract][Full Text] [Related]
6. RelB/p50 complexes regulate cytokine-induced YKL-40 expression.
Bhardwaj R; Yester JW; Singh SK; Biswas DD; Surace MJ; Waters MR; Hauser KF; Yao Z; Boyce BF; Kordula T
J Immunol; 2015 Mar; 194(6):2862-70. PubMed ID: 25681350
[TBL] [Abstract][Full Text] [Related]
7. Oncostatin M enhances the expression of prostaglandin E2 and cyclooxygenase-2 in astrocytes: synergy with interleukin-1beta, tumor necrosis factor-alpha, and bacterial lipopolysaccharide.
Repovic P; Mi K; Benveniste EN
Glia; 2003 Jun; 42(4):433-46. PubMed ID: 12730964
[TBL] [Abstract][Full Text] [Related]
8. CP690,550 inhibits oncostatin M-induced JAK/STAT signaling pathway in rheumatoid synoviocytes.
Migita K; Komori A; Torigoshi T; Maeda Y; Izumi Y; Jiuchi Y; Miyashita T; Nakamura M; Motokawa S; Ishibashi H
Arthritis Res Ther; 2011 May; 13(3):R72. PubMed ID: 21548952
[TBL] [Abstract][Full Text] [Related]
9. A non-canonical function of eukaryotic elongation factor 1A1: regulation of interleukin-6 expression.
Schulz I; Engel C; Niestroj AJ; Kehlen A; Rahfeld JU; Kleinschmidt M; Lehmann K; Roßner S; Demuth HU
Biochim Biophys Acta; 2014 May; 1843(5):965-75. PubMed ID: 24487064
[TBL] [Abstract][Full Text] [Related]
10. Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo?
Sriram K; Benkovic SA; Hebert MA; Miller DB; O'Callaghan JP
J Biol Chem; 2004 May; 279(19):19936-47. PubMed ID: 14996842
[TBL] [Abstract][Full Text] [Related]
11. Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines.
Fossey SL; Bear MD; Kisseberth WC; Pennell M; London CA
BMC Cancer; 2011 Apr; 11():125. PubMed ID: 21481226
[TBL] [Abstract][Full Text] [Related]
12. Oncostatin M promotes proliferation of ovarian cancer cells through signal transducer and activator of transcription 3.
Li Q; Zhu J; Sun F; Liu L; Liu X; Yue Y
Int J Mol Med; 2011 Jul; 28(1):101-8. PubMed ID: 21399864
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of a tyrosine-fructose Maillard reaction product, 2,4-bis(p-hydroxyphenyl)-2-butenal on amyloid-β generation and inflammatory reactions via inhibition of NF-κB and STAT3 activation in cultured astrocytes and microglial BV-2 cells.
Lee YJ; Choi DY; Choi IS; Han JY; Jeong HS; Han SB; Oh KW; Hong JT
J Neuroinflammation; 2011 Oct; 8():132. PubMed ID: 21982455
[TBL] [Abstract][Full Text] [Related]
14. Oncostatin M regulates SOCS3 mRNA stability via the MEK-ERK1/2-pathway independent of p38(MAPK)/MK2.
Ehlting C; Böhmer O; Hahnel MJ; Thomas M; Zanger UM; Gaestel M; Knoefel WT; Schulte Am Esch J; Häussinger D; Bode JG
Cell Signal; 2015 Mar; 27(3):555-67. PubMed ID: 25562430
[TBL] [Abstract][Full Text] [Related]
15. Luteolin and Apigenin Attenuate LPS-Induced Astrocyte Activation and Cytokine Production by Targeting MAPK, STAT3, and NF-κB Signaling Pathways.
Che DN; Cho BO; Kim JS; Shin JY; Kang HJ; Jang SI
Inflammation; 2020 Oct; 43(5):1716-1728. PubMed ID: 32462548
[TBL] [Abstract][Full Text] [Related]
16. Analysis of IL-6/gp130 family receptor expression reveals that in contrast to astroglia, microglia lack the oncostatin M receptor and functional responses to oncostatin M.
Hsu MP; Frausto R; Rose-John S; Campbell IL
Glia; 2015 Jan; 63(1):132-41. PubMed ID: 25103368
[TBL] [Abstract][Full Text] [Related]
17. Oncostatin M synergistically induces CXCL10 and ICAM-1 expression in IL-1beta-stimulated-human gingival fibroblasts.
Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
J Cell Biochem; 2010 Sep; 111(1):40-8. PubMed ID: 20680966
[TBL] [Abstract][Full Text] [Related]
18. HIV induces expression of complement component C3 in astrocytes by NF-κB-dependent activation of interleukin-6 synthesis.
Nitkiewicz J; Borjabad A; Morgello S; Murray J; Chao W; Emdad L; Fisher PB; Potash MJ; Volsky DJ
J Neuroinflammation; 2017 Jan; 14(1):23. PubMed ID: 28122624
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of interleukin-1beta-induced GDNF release from rat glioma cells.
Tanabe K; Nishimura K; Dohi S; Kozawa O
Brain Res; 2009 Jun; 1274():11-20. PubMed ID: 19362079
[TBL] [Abstract][Full Text] [Related]
20. 3-N-butylphthalide (NBP) attenuates the amyloid-β-induced inflammatory responses in cultured astrocytes via the nuclear factor-κB signaling pathway.
Wang HM; Zhang T; Huang JK; Sun XJ
Cell Physiol Biochem; 2013; 32(1):235-42. PubMed ID: 23899885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
